Michael McGrady Michael McGrady

    Michael is a journalist and researcher. His work has been supported by the Knowledge-Action-Change Tobacco Harm Reduction Scholarship program; the independently administered scholarship is supported by a grant from the Foundation for a Smoke-Free World. Michael is also the journalist-in-residence and visiting research fellow in tobacco and drug harm reduction policy at the American Consumer Institute, Center for Citizen Research. He conducts consumer-oriented and behavior research on the impacts of public health regulations on people who use drugs, especially nicotine. His work has appeared in the Wall Street Journal, the Hill and the South China Morning Post. He lives in Colorado.

    The Damage to Vape Shops Deemed “Non-Essential”—And Their Customers

    People who rely on vapes and other reduced-risk nicotine products—overwhelmingly former smokers, or those ...

    COVID-19 and Tobacco Harm Reduction: What’s the Relationship?

    At publication time, over 113,000 people worldwide were known to be infected by the ...

    How the British Approach to Vaping Puts the US to Shame

    Over the summer, US media reported that two National Health Service hospitals in England ...

    Vape Bans and Lung Disease: Picking Through the Feds’ Framing

    The feds have been publicly finessing their approach to vaping, amid national outcries over ...

    African Experts Explain Their Challenges in Reducing Tobacco Harms

    Major obstacles to tobacco harm reduction exist in high-income, “western” countries from the United ...

    The Year Is 2020, and the US Has Banned Vapes. What Happens Now?

    President Donald Trump finished his overture at this year’s Rx Drug Abuse and Heroin ...

    • 1
    • 2